Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,808 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06215274Recruiting
Leisure activities and early Alzheimer's study
This trial looks at how engaging in mentally stimulating leisure activities (like puzzles, reading, or games) may affect brain health in people with early memory concerns. Researchers want to understand the brain changes that happen with these activities.
Fuzhou, FujianAges 60 years+ - NCT06215378RecruitingPhase 3
Protamine Sulfate to Reverse Heparin After TAVI
This trial tests whether giving protamine sulfate after a TAVI procedure (aortic valve replacement through the leg) to reverse the blood thinner heparin is safe and effective. It may help reduce bleeding risk for patients.
Paris, Île-de-France RegionAges 18 years+ - NCT06216678Recruiting
Can healthy diets with plant oils improve heart health?
This study tests if adding plant oils to a healthy diet can improve cholesterol and other heart health markers in people with moderately high cholesterol. It involves following a specific meal plan and having your health monitored over several weeks.
University Park, PennsylvaniaAges 25–60 - NCT06216704Recruiting
Bone health and marrow study in teens with cystic fibrosis
This study looks at how cystic fibrosis affects bone health and bone marrow in teenagers. It uses a special MRI scan to measure bone strength and marrow composition, which may help doctors better understand and prevent bone problems in people with CF.
Boston, MassachusettsAges 13–20 - NCT06217302RecruitingPhase 3
Sotagliflozin for kidney protection in type 1 diabetes
This study tests whether sotagliflozin (a pill that helps control blood sugar and protects the kidneys) can slow down kidney function decline in people with type 1 diabetes and diabetic kidney disease. You may qualify if you have had type 1 diabetes for at least 8 years, have moderate kidney damage, and are on standard treatments.
Stanford, CaliforniaAges 18–75 - NCT06219239Recruiting
Gene therapy for transfusion-dependent beta-thalassemia
This trial tests a new gene therapy for people with beta-thalassemia who need regular blood transfusions. It uses a virus to deliver a working gene into your own stem cells, then those cells are put back into your body to help your body make healthy red blood cells.
Tianjin, Tianjin MunicipalityAges 3–35 - NCT06219486Recruiting
The safe fast track study for stable patients
This trial tests if stable emergency room patients can be safely monitored without immediate blood tests. It may help reduce waiting times and unnecessary procedures.
Esbjerg, SydAges 18 years+ - NCT06219421Recruiting
Using facial photos to understand genetic conditions
This study uses regular front and side facial photos to help doctors better understand facial features in people with genetic conditions or after surgery. It may help improve how we diagnose and care for these conditions.
ParisAges Any age - NCT06222164Recruiting
Using leftover patient samples for research
This study uses leftover blood, bone marrow, or tissue samples that were already sent to a specific lab (LabPMM) for testing. Researchers want to study these samples to learn more about diseases and improve future tests for patients.
San Diego, CaliforniaAges 18 years+ - NCT06223555Recruiting
Mixed meal energy study in healthy adults
This study looks at how your body responds to a mixed meal (a test drink or meal) when the calories are either fixed or adjusted to your energy needs. It may help researchers understand how to measure metabolism more accurately.
Phoenix, ArizonaAges 18–99 - NCT06223633Recruiting
Stent for sudden heart artery tears
This trial tests a special covered stent (a small mesh tube) for treating sudden tears in heart arteries or bypass grafts. If you have a perforation in a vessel of a certain size, this stent may help seal it and stop bleeding.
Dallas, TexasAges Any age - NCT06224140Recruiting
Dialysis without heparin: a safety study
This study tests whether dialysis can be done safely without using heparin (a blood thinner) in people with end-stage kidney disease. If successful, it could reduce the need for blood-thinning medications and their associated risks.
Marseille, Bouches du RhôneAges 18 years+ - NCT06225479Recruiting
Exercise for older men with urinary problems
This study tests whether a special exercise program can help older men with urinary symptoms from an enlarged prostate. You'll either exercise at home with a heart rate monitor or receive health education for 6 months.
San Francisco, CaliforniaAges 60 years+ - NCT06226272Recruiting
Study of Stryker spine device results
This trial is checking how well a Stryker spine device works in people who need spine surgery. Eligibility depends on the specific device and is decided by the study doctors.
Jacksonville, FloridaAges 18 years+ - NCT06228456RecruitingPhase 4
Low-dose ticagrelor vs clopidogrel for stable heart patients after stent
This trial tests whether a lower dose of the blood thinner ticagrelor works better than clopidogrel in people with stable coronary artery disease who are getting a planned stent. It aims to find which drug is safer and more effective for preventing future heart problems.
Jacksonville, FloridaAges 18 years+ - NCT06230185Recruiting
Blood test to monitor treatment response in triple-negative breast cancer
This trial is testing whether a blood test can track how well chemotherapy is working in people with early-stage triple-negative breast cancer. You would provide blood samples before and during treatment, and the results may help your doctor understand your response better.
Tucson, ArizonaAges 18 years+ - NCT06230406Recruiting
Gene study in atherosclerosis patients having surgery
This study looks at genes in people who have atherosclerosis (hardening of the arteries). It will check tissue samples taken during surgery to learn more about how the disease works.
San Donato Milanese, MilanAges Any age - NCT06230718Recruiting
Thinking about moving your arm after stroke
This study tests if thinking about moving your arm (motor imagery) and watching a video of arm movements can help you move better after a stroke. It uses a technique called EMG to measure muscle signals while you try or imagine moving.
Salamanca, SalamancaAges 18–99 - NCT06232551Recruiting
Hospital alert to prescribe rivaroxaban to prevent blood clots
This trial tests whether alerting your hospital doctor to prescribe a blood thinner called rivaroxaban (Xarelto) at discharge can help prevent dangerous blood clots in your legs or lungs. It is for patients who are at higher risk for clots but have a low bleeding risk.
Murray, UtahAges 18–110 - NCT06233110RecruitingPhase 1
Ruxolitinib and fostamatinib for steroid-resistant chronic GVHD
This study tests two drugs, ruxolitinib and fostamatinib, together for people with chronic graft-versus-host disease (GVHD) that hasn't responded well to steroids. The goal is to see if this combination can better control GVHD.
Durham, North CarolinaAges 18–80 - NCT06232954Recruiting
Testing a mosquito-repelling device to prevent malaria in kids
This trial is testing a special device that releases a scent to repel mosquitoes, aiming to reduce malaria in young children in Uganda. If you have a child under 5 and are willing to use the device in your home, this study could help protect your child from malaria.
JinjaAges Up to 5 years - NCT06234410Recruiting
Heart risk check before kidney transplant
This study uses a special heart CT scan (called coronary angiography) to check the heart health of people waiting for a kidney transplant. It aims to see if this scan can help doctors better assess and manage heart risks before surgery.
Edinburgh, LothianAges 16 years+ - NCT06237179RecruitingPhase 1/Phase 2
Exercise program to reduce heart risk in prostate cancer
This study tests whether a supervised exercise program can help reduce heart disease risk in men with prostate cancer who are on hormone therapy. Participants will exercise at home or in a group and be monitored for heart health changes.
Richmond, VirginiaAges 40–85 - NCT06236438RecruitingPhase 2/Phase 3
Livmoniplimab plus budigalimab and chemo for untreated lung cancer
This trial tests a new combination of two immune system drugs (livmoniplimab and budigalimab) plus standard chemotherapy compared to the current standard treatment (pembrolizumab plus chemo) for people with advanced non-small cell lung cancer that has not been treated yet. The goal is to see if the new combination works better at controlling the cancer.
La Jolla, CaliforniaAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,808 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.